Lansoprazole for secondary prevention of gastric or duodenal ulcers associated with long-term non-steroidal anti-inflammatory drug (NSAID) therapy: results of a prospective, multicenter, double-blind, randomized, double-dummy, active-controlled trial

BACKGROUND: Low-dose lansoprazole has not been intensively evaluated for its efficacy in the prevention of recurrent gastric or duodenal ulcers in patients receiving long-term non-steroidal anti-inflammatory drug (NSAID) therapy for pain relief in such diseases as rheumatoid arthritis, osteoarthriti...

Descripción completa

Detalles Bibliográficos
Autores principales: Sugano, Kentaro, Kontani, Teiji, Katsuo, Shinichi, Takei, Yoshinori, Sakaki, Nobuhiro, Ashida, Kiyoshi, Mizokami, Yuji, Asaka, Masahiro, Matsui, Shigeyuki, Kanto, Tatsuya, Soen, Satoshi, Takeuchi, Tsutomu, Hiraishi, Hideyuki, Hiramatsu, Naoki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Japan 2012
Materias:
Original Article—Alimentary Tract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3360874/
https://www.ncbi.nlm.nih.gov/pubmed/22388884
http://dx.doi.org/10.1007/s00535-012-0541-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3360874/
https://www.ncbi.nlm.nih.gov/pubmed/22388884
http://dx.doi.org/10.1007/s00535-012-0541-z

Ejemplares similares